Jed E Black
Affiliation: Stanford University
- Conditions of primary excessive daytime sleepinessJed E Black
Stanford Sleep Disorders Center, Sleep Medicine Division, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA
Neurol Clin 23:1025-44. 2005..Several methods have been developed to assess EDS, although each of them has limitations. Treatment is available for the great majority of cases...
- The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findingsJed Black
Stanford University, Palo Alto, CA, USA Electronic address
Sleep Med 15:522-9. 2014..The aim of this study was to characterize health-care utilization, costs, and productivity in a large population of patients diagnosed with narcolepsy in the United States...
- The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsyJed Black
Stanford Sleep Medicine Center, 450 Broadway Street, pavilion B, 2nd Floor, Redwood City, CA 94063 5730, USA
J Clin Sleep Med 6:596-602. 2010....
- Sleepiness and residual sleepiness in adults with obstructive sleep apneaJed Black
Stanford University Sleep Research Center, 401 Quarry Road, 3301, Stanford, CA 94305, USA
Respir Physiol Neurobiol 136:211-20. 2003..Recently, however, data from clinical trials have been generated which provide direction in the evaluation and management of the OSA patient suffering residual daytime sleepiness...
- The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension studyJed E Black
Actelion Pharmaceuticals, Allschwil, Switzerland
J Clin Sleep Med 6:458-66. 2010..This study evaluated the tolerability and efficacy of armodafinil for > or = 12 months...
- Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndromeJed E Black
Stanford Sleep Disorder Clinic, Stanford University, Stanford, CA 94305, USA
Sleep 28:464-71. 2005..We evaluated the efficacy and safety of the wake-promoting agent modafinil for treating residual excessive sleepiness in nCPAP-treated patients...
- Sodium oxybate improves excessive daytime sleepiness in narcolepsyJed Black
Stanford Sleep Disorders Clinic, CA 94305, USA
Sleep 29:939-46. 2006..To assess the effectiveness of sodium oxybate therapy, modafinil therapy and the combination of the two for excessive daytime sleepiness in narcolepsy patients previously taking modafinil...
- The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsyJed Black
Stanford Sleep Disorders Clinic, 401 Quary Road, Stanford, CA 94305, USA
Sleep Med 10:829-35. 2009..The present study provided an opportunity to further characterize these sleep-related effects in patients with narcolepsy during treatment with sodium oxybate as monotherapy or in combination with modafinil...
- Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studiesRita A Popat
Dept of Health Research and Policy, Division of Epidemiology, HRP Redwood Building, Room T209, Stanford University School of Medicine, Stanford, CA 94305 5405, USA
Sleep Med 11:154-60. 2010..We evaluated the reliability and validity of this RLS-NIH questionnaire in a community-based sample and concurrently developed and evaluated the utility of an expanded screening questionnaire, the RLS-EXP...
- Recent advances in the treatment and management of excessive daytime sleepinessJed Black
Stanford Sleep Medicine Center, Stanford University, Palo Alto, CA, USA
CNS Spectr 12:1-14; quiz 15. 2007..Finally, Mary B. O'Malley, MD, PhD, reviews treatment of EDS, including counseling on sleep hygiene and duration of sleep, mechanical treatments, bright-light therapy, and wake-promoting medications...
- The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomniasEmmanuel Mignot
Center for Narcolepsy, Stanford University, 701B Lower Welch Rd, Palo Alto, CA 94304 5742, USA
Arch Neurol 59:1553-62. 2002..Narcolepsy, a neurological disorder affecting 1 in 2000 individuals, is associated with HLA-DQB1*0602 and low cerebrospinal fluid (CSF) hypocretin (orexin) levels...
- Novel therapies for narcolepsyStephen Brooks
Stanford Sleep Disorders Clinic, 401 Quarry Road, Suite 3301, Stanford CA 94305, USA
Expert Opin Investig Drugs 11:1821-7. 2002..It is important to emphasise that, although narcolepsy is not a common disorder, new agents for its treatment will undoubtedly find more extensive use in other conditions...
- Narcolepsy and syndromes of primary excessive daytime somnolenceJed E Black
Stanford Sleep Disorders Center, Stanford University, California, USA
Semin Neurol 24:271-82. 2004..Finally, in view of the tremendous advances that have occurred in the past few years in our understanding of the pathophysiology of canine and human narcolepsy, we also highlight these discoveries...
- Excessive daytime sleepiness: considerations for the psychiatristScott M Leibowitz
Sleep Disorders Center of CDS, Atlanta, GA, USA
Psychiatr Clin North Am 29:921-45; abstract viii. 2006..This article summarizes the clinical presentation, the differential diagnosis, commonly used diagnostic tools, and treatment options for patients complaining of excessive daytime sleepiness...